Literature DB >> 24135009

Time to get serious about improving the safety of oral chemotherapy.

Monika K Krzyzanowska.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24135009      PMCID： PMC3969005          DOI： 10.1200/JOP.2013.000913

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  7 in total

1.  Revisions to the 2009 american society of clinical oncology/oncology nursing society chemotherapy administration safety standards: expanding the scope to include inpatient settings.

Authors:  Joseph O Jacobson; Martha Polovich; Terry R Gilmore; Lisa Schulmeister; Peg Esper; Kristine B Lefebvre; Michael N Neuss
Journal:  J Oncol Pract       Date:  2011-12-13       Impact factor: 3.840

2.  US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards.

Authors:  Saul N Weingart; Justin W Li; Junya Zhu; Laurinda Morway; Sherri O Stuver; Lawrence N Shulman; Michael J Hassett
Journal:  J Oncol Pract       Date:  2011-12-06       Impact factor: 3.840

3.  Experience-based design: from redesigning the system around the patient to co-designing services with the patient.

Authors:  Paul Bate; Glenn Robert
Journal:  Qual Saf Health Care       Date:  2006-10

Review 4.  Patient adherence and persistence with oral anticancer treatment.

Authors:  Kathryn Ruddy; Erica Mayer; Ann Partridge
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

5.  American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards.

Authors:  Joseph O Jacobson; Martha Polovich; Kristen K McNiff; Kristine B Lefebvre; Charmaine Cummings; Michele Galioto; Katherine R Bonelli; Michele R McCorkle
Journal:  J Clin Oncol       Date:  2009-09-28       Impact factor: 44.544

6.  2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.

Authors:  Michael N Neuss; Martha Polovich; Kristen McNiff; Peg Esper; Terry R Gilmore; Kristine B LeFebvre; Lisa Schulmeister; Joseph O Jacobson
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

7.  Quality Oncology Practice Initiative Certification Program: measuring implementation of chemotherapy administration safety standards in the outpatient oncology setting.

Authors:  Terry R Gilmore; Lisa Schulmeister; Joseph O Jacobson
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840
  7 in total
  2 in total

1.  Adherence to abiraterone among the first 86 recipients after release in Saskatchewan.

Authors:  A D Smith; C Olson; B Lyons; D Tran; D F Blackburn
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

2.  Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial.

Authors:  Chloé Gervès-Pinquié; Fatima Daumas-Yatim; Benoît Lalloué; Anne Girault; Marie Ferrua; Aude Fourcade; François Lemare; Mario Dipalma; Etienne Minvielle
Journal:  BMC Health Serv Res       Date:  2017-02-13       Impact factor: 2.655
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.